Regulatory TYKERB® Tablets PMS

Mise à jour : Il y a 4 ans
Référence : NCT00975988

Femme et Homme

Extrait

Non-interventional, open-label, single group, multicentric post-marketing surveillance to monitor the safety and effectiveness of TYKERB® tablets administered in Korean patients according to the prescribing information TYKERB® is a registered trademark of the GlaxoSmithKline group of companies.


Critère d'inclusion

  • Cancer

Liens